CEFIDEROCOL SULFATE TOSYLATE

CEFIDEROCOL SULFATE TOSYLATE was reported 315 times

CEFIDEROCOL SULFATE TOSYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TONGUE ROUGH 2 0.0235
1 BILE DUCT NECROSIS 1 0.0164
2 ACINETOBACTER SEPSIS 1 0.0156
3 MENINGITIS CANDIDA 1 0.0143
4 BURKHOLDERIA INFECTION 1 0.0120
5 TRACHEAL INFLAMMATION 1 0.0092
6 VASCULAR DEVICE OCCLUSION 3 0.0088
7 HEPATOSPLENIC CANDIDIASIS 1 0.0068
8 ACINETOBACTER BACTERAEMIA 1 0.0053
9 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 2 0.0049
10 RIB DEFORMITY 1 0.0039
11 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
12 MEDIASTINITIS 2 0.0034
13 PEPTIC ULCER HAEMORRHAGE 2 0.0029
14 PULMONARY RENAL SYNDROME 1 0.0029
15 TONGUE ERYTHEMA 2 0.0024
16 SICKLE CELL DISEASE 1 0.0022
17 METAPLASIA 1 0.0021
18 PULMONARY MUCORMYCOSIS 1 0.0019
19 PATHOGEN RESISTANCE 17 0.0019
20 SPUTUM PURULENT 1 0.0015
21 FUSARIUM INFECTION 1 0.0014
22 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
23 EXCESSIVE GRANULATION TISSUE 1 0.0012
24 DRUG RESISTANCE 31 0.0012
25 HEPATIC CYTOLYSIS 14 0.0011
26 DYSENTERY 2 0.0011
27 BLOOD URINE 1 0.0010
28 LUNG ABSCESS 2 0.0010
29 VANISHING BILE DUCT SYNDROME 1 0.0009
30 INFECTION REACTIVATION 1 0.0009
31 AMPUTATION 1 0.0008
32 SYSTEMIC CANDIDA 2 0.0008
33 INFECTIOUS PLEURAL EFFUSION 1 0.0007
34 CHOLESTASIS 12 0.0006
35 LIVER ABSCESS 2 0.0006
36 LEUKAEMIA RECURRENT 1 0.0006
37 TREATMENT DELAYED 1 0.0006
38 PSEUDOMONAL SEPSIS 1 0.0006
39 BLADDER SPASM 1 0.0005
40 MECHANICAL VENTILATION 1 0.0005
41 DEVICE RELATED SEPSIS 1 0.0005
42 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
43 NOSOCOMIAL INFECTION 1 0.0005
44 ENCEPHALITIS 3 0.0004
45 ENCEPHALOPATHY 10 0.0004
46 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
47 CHROMATURIA 9 0.0004
48 ABDOMINAL INFECTION 1 0.0004
49 RENAL TUBULAR DISORDER 1 0.0004
50 HAEMATOLOGICAL MALIGNANCY 1 0.0004
51 COVID-19 PNEUMONIA 4 0.0003
52 LUNG ADENOCARCINOMA 1 0.0003
53 TREATMENT FAILURE 27 0.0003
54 EOSINOPHILIC PNEUMONIA 1 0.0003
55 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
56 TYPE I HYPERSENSITIVITY 1 0.0003
57 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
58 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
59 STATUS EPILEPTICUS 3 0.0003
60 PRODUCT STORAGE ISSUE 1 0.0003
61 LIPASE INCREASED 2 0.0003
62 SEPTIC SHOCK 11 0.0003
63 ORGAN FAILURE 1 0.0002
64 EMBOLISM 2 0.0002
65 PRODUCT DISPENSING ISSUE 1 0.0002
66 MYOPATHY 2 0.0002
67 URINE ABNORMALITY 1 0.0002
68 STAPHYLOCOCCAL SEPSIS 1 0.0002
69 HYPERVOLAEMIA 1 0.0002
70 HYPERNATRAEMIA 1 0.0002
71 KLEBSIELLA INFECTION 1 0.0002
72 TOXIC ENCEPHALOPATHY 1 0.0002
73 HYPERBILIRUBINAEMIA 2 0.0002
74 PARTIAL SEIZURES 1 0.0002
75 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
76 RASH MACULO-PAPULAR 4 0.0002
77 CANDIDA INFECTION 3 0.0002
78 EOSINOPHILIA 3 0.0002
79 BACTERAEMIA 2 0.0002
80 MYOCLONUS 2 0.0002
81 LARYNGEAL OEDEMA 1 0.0002
82 CHOLANGITIS 1 0.0002
83 OLIGURIA 1 0.0002
84 HAIR COLOUR CHANGES 2 0.0002
85 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
86 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
87 PRESCRIBED OVERDOSE 3 0.0002
88 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
89 ACUTE KIDNEY INJURY 23 0.0002
90 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
91 COLITIS ISCHAEMIC 1 0.0001
92 PRODUCT LABEL ISSUE 1 0.0001
93 MOUTH HAEMORRHAGE 1 0.0001
94 HAEMODYNAMIC INSTABILITY 1 0.0001
95 EPILEPSY 4 0.0001
96 ACUTE MYELOID LEUKAEMIA 2 0.0001
97 POST PROCEDURAL INFECTION 1 0.0001
98 COAGULOPATHY 2 0.0001
99 EOSINOPHIL COUNT INCREASED 1 0.0001
100 PSEUDOMONAS INFECTION 1 0.0001
101 ANURIA 1 0.0001
102 TUMOUR LYSIS SYNDROME 1 0.0001
103 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
104 HAEMOLYTIC ANAEMIA 1 0.0001
105 MEDICATION ERROR 6 0.0001
106 HEPATIC FUNCTION ABNORMAL 4 0.0001
107 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
108 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
109 RENAL TUBULAR NECROSIS 1 0.0001
110 SUBARACHNOID HAEMORRHAGE 1 0.0001
111 BRADYCARDIA 5 0.0001
112 LIVER FUNCTION TEST INCREASED 2 0.0001
113 STEVENS-JOHNSON SYNDROME 2 0.0001
114 HEPATOTOXICITY 2 0.0001
115 INFECTION 13 0.0001
116 DERMATITIS CONTACT 1 0.0001
117 METASTASES TO LUNG 1 0.0001
118 ELECTROLYTE IMBALANCE 1 0.0001
119 DEATH 71 0.0001
120 SEPSIS 9 0.0001
121 PRODUCT STORAGE ERROR 7 0.0001
122 MUSCLE ATROPHY 1 0.0001
123 MUCOSAL INFLAMMATION 2 0.0001
124 HAEMOPTYSIS 2 0.0001
125 BRONCHOSPASM 1 0.0001
126 LABORATORY TEST ABNORMAL 2 0.0001
127 DEVICE RELATED INFECTION 1 0.0001
128 THERAPY PARTIAL RESPONDER 1 0.0001
129 HALLUCINATION, AUDITORY 1 0.0001
130 THROMBOCYTOPENIA 7 0.0001
131 FUNGAL INFECTION 2 0.0001
132 LEUKOPENIA 3 0.0001
133 BLOOD UREA INCREASED 1 0.0001
134 CIRCULATORY COLLAPSE 1 0.0001
135 DRUG ERUPTION 1 0.0001
136 LEUKOCYTOSIS 1 0.0001
137 NO ADVERSE EVENT 10 0.0001
138 RESPIRATORY FAILURE 4 0.0001
139 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
140 ANAPHYLACTIC REACTION 3 0.0001
141 AGRANULOCYTOSIS 1 0.0001
142 BACTERIAL INFECTION 1 0.0001
143 POST PROCEDURAL COMPLICATION 1 0.0001
144 ACUTE RESPIRATORY FAILURE 1 0.0001
145 EAR PAIN 1 0.0001
146 PRESCRIBED UNDERDOSE 1 0.0001
147 RIB FRACTURE 1 0.0000
148 CARDIAC ARREST 4 0.0000
149 CARDIO-RESPIRATORY ARREST 2 0.0000
150 MOUTH ULCERATION 1 0.0000
151 RETCHING 1 0.0000
152 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
153 BLOOD CREATININE INCREASED 3 0.0000
154 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
155 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
156 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
157 RASH ERYTHEMATOUS 2 0.0000
158 NEURALGIA 1 0.0000
159 CEREBRAL INFARCTION 1 0.0000
160 BLOOD BILIRUBIN INCREASED 1 0.0000
161 RESPIRATORY DISTRESS 1 0.0000
162 CONDITION AGGRAVATED 11 0.0000
163 RENAL IMPAIRMENT 3 0.0000
164 STOMATITIS 2 0.0000
165 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
166 NERVOUS SYSTEM DISORDER 1 0.0000
167 DRUG-INDUCED LIVER INJURY 1 0.0000
168 NIGHT SWEATS 1 0.0000
169 LACTIC ACIDOSIS 1 0.0000
170 STAPHYLOCOCCAL INFECTION 1 0.0000
171 FEBRILE NEUTROPENIA 2 0.0000
172 OFF LABEL USE 26 0.0000
173 HAEMATURIA 1 0.0000
174 NEOPLASM PROGRESSION 1 0.0000
175 HYPOXIA 1 0.0000
176 SKIN BURNING SENSATION 2 0.0000
177 PNEUMONIA 9 0.0000
178 C-REACTIVE PROTEIN INCREASED 1 0.0000
179 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
180 DISEASE PROGRESSION 3 0.0000
181 DISORIENTATION 1 0.0000
182 DRY MOUTH 2 0.0000
183 BLINDNESS 1 0.0000
184 NEUTROPHIL COUNT DECREASED 1 0.0000
185 RHABDOMYOLYSIS 1 0.0000
186 URTICARIA 4 0.0000
187 SKIN EXFOLIATION 2 0.0000
188 ANGIOEDEMA 1 0.0000
189 LIVER DISORDER 1 0.0000
190 THROAT IRRITATION 1 0.0000
191 THERAPY NON-RESPONDER 1 0.0000
192 LUNG DISORDER 1 0.0000
193 FLUSHING 2 0.0000
194 THERAPY CESSATION 1 0.0000
195 DEPRESSED MOOD 1 0.0000
196 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
197 OEDEMA 1 0.0000
198 HYPONATRAEMIA 1 0.0000
199 INTENTIONAL OVERDOSE 1 0.0000
200 DEEP VEIN THROMBOSIS 1 0.0000
201 DRY SKIN 2 0.0000
202 HEPATIC ENZYME INCREASED 1 0.0000
203 PYREXIA 5 0.0000
204 OVERDOSE 3 0.0000
205 RASH 6 0.0000
206 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
207 TACHYCARDIA 1 0.0000
208 ADVERSE DRUG REACTION 1 0.0000
209 NASOPHARYNGITIS 2 0.0000
210 CHEST PAIN 2 0.0000
211 HYPERSENSITIVITY 2 0.0000
212 DYSPHAGIA 1 0.0000
213 ILLNESS 1 0.0000
214 PLATELET COUNT DECREASED 1 0.0000
215 CONSTIPATION 2 0.0000
216 DECREASED APPETITE 2 0.0000
217 CHILLS 1 0.0000
218 LOSS OF CONSCIOUSNESS 1 0.0000
219 HYPERHIDROSIS 1 0.0000
220 RENAL FAILURE 1 0.0000
221 INSOMNIA 2 0.0000
222 NEUTROPENIA 1 0.0000
223 WEIGHT DECREASED 2 0.0000
224 COUGH 2 0.0000
225 VOMITING 3 0.0000
226 PARAESTHESIA 1 0.0000
227 DRUG INTERACTION 1 0.0000
228 DIARRHOEA 4 0.0000
229 URINARY TRACT INFECTION 1 0.0000
230 COVID-19 1 0.0000
231 SOMNOLENCE 1 0.0000
232 ERYTHEMA 1 0.0000
233 ARTHRALGIA 2 0.0000
234 HYPERTENSION 1 0.0000
235 DRUG INEFFECTIVE 6 0.0000
236 BACK PAIN 1 0.0000
237 NAUSEA 3 0.0000
238 PRODUCT DOSE OMISSION ISSUE 1 0.0000
239 HEADACHE 2 0.0000
240 FATIGUE 2 0.0000
241 DYSPNOEA 1 0.0000